Position in XNCR
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$10,950,930
+$3,464,613 QoQ
Shares Held
680,182
+9.6% QoQ
Ownership
0.915%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#24
of 208 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 47%
Shared 0%
None 53%
Common Shares in XNCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $624,607,308 across 78 Biotechnology names. XNCR ranks #15 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
175,291 | $109,300,950 | |
| 2 | INCY |
Incyte Corp
|
881,889 | $99,970,937 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
664,031 | $40,080,911 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
337,461 | $39,506,559 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
490,724 | $27,878,030 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
104,935 | $25,286,186 | |
| 7 | RLAY |
Relay Therapeutics, Inc.
|
1,291,182 | $24,158,015 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
572,538 | $21,304,138 |
All Filings in XNCR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,950,930 | 680,182 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $7,486,317 | 620,756 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $8,937,641 | 583,778 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,284,670 | 621,029 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,842,691 | 488,892 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,089,089 | 290,328 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $694,087 | 30,204 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $994,620 | 49,459 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,398,858 | 232,375 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $4,698,907 | 212,332 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $4,634,254 | 218,288 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $3,077,308 | 152,720 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $3,342,908 | 133,877 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $4,408,655 | 158,073 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,793,088 | 68,859 | Shares | Sole | 2023-02-13 | |
| 2021-09-30 | $372,421 | 11,403 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $5,632,320 | 163,303 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $6,899,719 | 160,235 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $11,475,606 | 263,021 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $10,344,827 | 266,688 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $8,916,869 | 275,297 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $7,317,372 | 244,892 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||